| Financial Year |
March 31 2023 |
| Monetary Funds |
830,694,631.18 |
| Held-for-trading Financial Assets |
680,761,416.66 |
| Notes Receivable |
-- |
| Accounts Receivable |
2,203,667,544.92 |
| Advances to Suppliers |
8,847,767.09 |
| Other Receivables |
16,344,799.42 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
40,936,000.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
203,630,772.61 |
| Total Current Assets |
3,984,882,932.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
86,286,488.76 |
| Investment Properties |
-- |
| Fixed Assetes |
7,527,939,695.70 |
| Under-construction Projects |
14,167,810.35 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
122,284,942.67 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
70,854,576.79 |
| Deferred Income Tax Assets |
62,591,231.94 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
7,891,841,363.83 |
| Total Assets |
11,876,724,295.94 |
| Short-Term Loans |
300,243,955.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
909,289,447.32 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,291,327.67 |
| Taxes Payable |
69,811,109.22 |
| Interest Payable |
-- |
| Dividend Payable |
3,692,792.03 |
| Other payables |
16,022,724.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
368,026,098.75 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
1,677,684,662.58 |
| Long-term Loans |
2,142,768,361.10 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,621,639,694.57 |
| Special Payable |
-- |
| Estimatied Liabilities |
151,482,262.11 |
| Deferred Income Tax Liabilities |
42,401,206.25 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,965,818,955.12 |
| Total Liabilities |
5,643,503,617.70 |
| Paid-In Capital(Or Share Stock) |
1,902,996,143.00 |
| Capital Surplus |
2,943,977,083.28 |
| Surplus Reserve |
98,028,493.78 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,085,099,954.68 |
| Minority Stockholder's Interest |
197,237,495.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,035,983,182.65 |
| Owner's Equity（Stockholder's Equity） |
6,233,220,678.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,876,724,295.94 |
